Liping Xu

1.7k citations
48 papers · 1.1k indexed · h-index 20
Topics
Parkinson's Disease Mechanisms and Treatments (6 papers)Neuroscience and Neuropharmacology Research (6 papers)Epigenetics and DNA Methylation (4 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Liping Xu

43 papers receiving 1.1k citations

Peers

Liping Xu
Comparison fields: 5 of 90
  • Molecular Biology 561
  • Oncology 161
  • Cancer Research 143
  • Cellular and Molecular Neuroscience 111
  • Neurology 110
Replace Honghai Wu with:
Honghai Wu China
Yu‐Long Lan China
Usha Gundimeda United States
Rabab H. Sayed Egypt
Ayman E. El-Sahar Egypt
Weijiang Zhao China
Maria Paola Cerù Italy
Yejun Tan United States
M. Zarándi Hungary
Hong Ao United States
Liping Xu relative to Honghai Wu China Honghai Wu's profile →
Citations per field
00.5×4.6×
Honghai Wu · 1×
Citations per year

Countries citing papers authored by Liping Xu

Since Specialization
Citations

This map shows the geographic impact of Liping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liping Xu more than expected).

Fields of papers citing papers by Liping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liping Xu. The network helps show where Liping Xu may publish in the future.

Co-authorship network of co-authors of Liping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Liping Xu. A scholar is included among the top collaborators of Liping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liping Xu. Liping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 0
5 0
6 6
7 7
8 9
9 16
10 14
11 12
12 49
13 7
14 16
15 8
16 54
17 20
18 40
19 14
20 35

About Liping Xu

Liping Xu is a scholar working on Biological Psychiatry, Physiology and Behavioral Neuroscience, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Biological Psychiatry (65 citations), Behavioral Neuroscience (38 citations) and Cancer Research (143 citations). Liping Xu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Aloke K. Dutta, Shuping Yin, Kaladhar B. Reddy, Yamin Liu, Yucheng Li, Ji-Duo Shen, Li‐Tao Yi, Hanbing Li, Jian Zhao and Lingling Zhai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026